Hiroki Gunji

682 total citations
23 papers, 434 citations indexed

About

Hiroki Gunji is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Hiroki Gunji has authored 23 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 9 papers in Molecular Biology and 8 papers in Pharmacology. Recurrent topics in Hiroki Gunji's work include Microbial Natural Products and Biosynthesis (8 papers), Carbohydrate Chemistry and Synthesis (5 papers) and Marine Sponges and Natural Products (5 papers). Hiroki Gunji is often cited by papers focused on Microbial Natural Products and Biosynthesis (8 papers), Carbohydrate Chemistry and Synthesis (5 papers) and Marine Sponges and Natural Products (5 papers). Hiroki Gunji collaborates with scholars based in Japan, Switzerland and United States. Hiroki Gunji's co-authors include Kuniaki Tatsuta, Andrea Vasella, Takashi Ishiyama, C. Richard Hutchinson, John F. Andersen, Shigeru Ohta, Yoshiyuki Kobayashi, Kazuma Murakami, Kazuhiro Irie and Masaaki Takahashi and has published in prestigious journals such as Biochemistry, Chemical Communications and Tetrahedron Letters.

In The Last Decade

Hiroki Gunji

23 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroki Gunji Japan 14 231 215 125 58 45 23 434
Tina M. Hallis United States 11 149 0.6× 320 1.5× 69 0.6× 30 0.5× 55 1.2× 18 513
A. Mayweg Switzerland 13 308 1.3× 189 0.9× 117 0.9× 32 0.6× 21 0.5× 19 576
Jane L. Wang United States 10 310 1.3× 121 0.6× 260 2.1× 26 0.4× 16 0.4× 10 535
Brian Heasley United States 12 294 1.3× 351 1.6× 50 0.4× 53 0.9× 23 0.5× 14 637
Laura Piccagli Italy 12 251 1.1× 223 1.0× 54 0.4× 60 1.0× 18 0.4× 12 527
Jacques Y. Roberge United States 15 312 1.4× 343 1.6× 49 0.4× 19 0.3× 18 0.4× 33 605
Guo-Hua Gong China 14 390 1.7× 234 1.1× 63 0.5× 52 0.9× 16 0.4× 23 662
Shweta Sinha India 12 230 1.0× 120 0.6× 81 0.6× 27 0.5× 11 0.2× 21 427
M. S. Frasinyuk Ukraine 15 444 1.9× 285 1.3× 331 2.6× 27 0.5× 15 0.3× 102 707
Khairia M. Youssef Egypt 12 455 2.0× 307 1.4× 96 0.8× 15 0.3× 41 0.9× 26 718

Countries citing papers authored by Hiroki Gunji

Since Specialization
Citations

This map shows the geographic impact of Hiroki Gunji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Gunji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Gunji more than expected).

Fields of papers citing papers by Hiroki Gunji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroki Gunji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Gunji. The network helps show where Hiroki Gunji may publish in the future.

Co-authorship network of co-authors of Hiroki Gunji

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroki Gunji. A scholar is included among the top collaborators of Hiroki Gunji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroki Gunji. Hiroki Gunji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murakami, Kazuma, et al.. (2022). Activity-differential search for amyloid-β aggregation inhibitors using LC-MS combined with principal component analysis. Bioorganic & Medicinal Chemistry Letters. 61. 128613–128613. 6 indexed citations
3.
Ehara, Takeru, Takatoshi Kosaka, Takanori Kanazawa, et al.. (2014). Structure-Based Design of Substituted Piperidines as a New Class of Highly Efficacious Oral Direct Renin Inhibitors. ACS Medicinal Chemistry Letters. 5(7). 787–792. 10 indexed citations
4.
Ehara, Takeru, Fumiaki Yokokawa, Junichi Sakaki, et al.. (2008). Discovery of selective and nonpeptidic cathepsin S inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(14). 3959–3962. 14 indexed citations
5.
Yokokawa, Fumiaki, Takeru Ehara, Yuki Iwaki, et al.. (2008). 4-Amino-2-cyanopyrimidines: Novel scaffold for nonpeptidic cathepsin S inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(16). 4642–4646. 10 indexed citations
6.
Sakaki, Junichi, Hiroki Gunji, Yuki Matsumoto, et al.. (2007). Synthesis and structure–activity relationship of novel RXR antagonists: Orally active anti-diabetic and anti-obesity agents. Bioorganic & Medicinal Chemistry Letters. 17(17). 4804–4807. 18 indexed citations
7.
Sakaki, Junichi, Hiroki Gunji, Takanori Kanazawa, et al.. (2007). Synthesis and structure–activity relationship of RXR antagonists based on the diazepinylbenzoic acid structure. Bioorganic & Medicinal Chemistry Letters. 17(17). 4808–4811. 25 indexed citations
8.
Tatsuta, Kuniaki, et al.. (2000). The First Total Synthesis of Natural (−)-Tetracycline. Chemistry Letters. 29(6). 646–647. 33 indexed citations
9.
Gunji, Hiroki & Andrea Vasella. (2000). Oligonucleosides with a Nucleobase-Including Backbone, Part 3, Synthesis of Acetyleno-Linked Adenosine Dimers. Helvetica Chimica Acta. 83(11). 2975–2992. 17 indexed citations
10.
Gunji, Hiroki & Andrea Vasella. (2000). Oligonucleosides with a Nucleobase-Including Backbone, Part 4, A Convergent Synthesis of Ethynediyl-Linked Adenosine Tetramers. Helvetica Chimica Acta. 83(12). 3229–3245. 13 indexed citations
11.
Tatsuta, Kuniaki, et al.. (2000). ChemInform Abstract: The First Total Synthesis of Natural (‐)‐Tetracycline.. ChemInform. 31(44). 2 indexed citations
12.
Gunji, Hiroki & Andrea Vasella. (2000). Oligonucleosides with a Nucleobase-Including Backbone, Part 2, Synthesis and Structure Determination of Adenosine-Derived Monomers. Helvetica Chimica Acta. 83(7). 1331–1345. 18 indexed citations
13.
Tatsuta, Kuniaki, et al.. (1997). Total Synthesis of MS-444, a Myosin Light Chain Kinase Inhibitor. The Journal of Antibiotics. 50(3). 289–290. 12 indexed citations
14.
Tatsuta, Kuniaki, et al.. (1995). Total syntheses of de-branched nagstatin and its analogs having glycosidase inhibiting activities. Tetrahedron Letters. 36(7). 1085–1088. 39 indexed citations
15.
Andersen, John F., Kuniaki Tatsuta, Hiroki Gunji, Takashi Ishiyama, & C. Richard Hutchinson. (1993). Substrate specificity of 6-deoxyerythronolide B hydroxylase, a bacterial cytochrome P450 of erythromycin A biosynthesis. Biochemistry. 32(8). 1905–1913. 69 indexed citations
16.
Tatsuta, Kuniaki, et al.. (1993). A practical preparation of (Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(methoxyimino)acetic acid. Tetrahedron Letters. 34(40). 6423–6426. 5 indexed citations
17.
Tatsuta, Kuniaki, et al.. (1990). Biosynthetic studies on oleandomycin by incorporation of the chemically synthesized aglycones.. The Journal of Antibiotics. 43(7). 909–911. 12 indexed citations
18.
Tatsuta, Kuniaki, et al.. (1990). The total synthesis of oleandomycin. Tetrahedron Letters. 31(5). 709–712. 14 indexed citations
19.
Tatsuta, Kuniaki, Yoshiyuki Kobayashi, & Hiroki Gunji. (1988). Synthesis of the intact aglycone of oleandomycin, oleandolide, and deoleandrosyl-oleandomycin.. The Journal of Antibiotics. 41(10). 1520–1523. 3 indexed citations
20.
Tatsuta, Kuniaki, et al.. (1988). Synthesis of oleandomycin through the intact aglycone, oleandolide. Tetrahedron Letters. 29(32). 3975–3978. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026